{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:04:04Z","timestamp":1793037844873,"version":"4.5.0"},"reference-count":111,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Obesity is a known factor in the development of preeclampsia. This paper links adipose tissue pathologies with aberrant placental development and the resulting preeclampsia. PPAR\u03b3, a transcription factor from the ligand-activated nuclear hormone receptor family, appears to be one common aspect of both pathologies. It is the master regulator of adipogenesis in humans. At the same time, its aberrantly low activity has been observed in placental pathologies. Overweight and obesity are very serious health problems worldwide. They have negative effects on the overall mortality rate. Very importantly, they are also conducive to diseases linked to impaired placental development, including preeclampsia. More and more people in Europe are suffering from overweight (35.2%) and obesity (16%) (EUROSTAT 2021 data), some of them young women planning pregnancy. As a result, we will be increasingly encountering obese pregnant women with a considerable risk of placental development disorders, including preeclampsia. An appreciation of the mechanisms shared by these two conditions may assist in their prevention and treatment. Clearly, it should not be forgotten that health education concerning the need for a proper diet and physical activity is of utmost importance here.<\/jats:p>","DOI":"10.3390\/ijms222313167","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T02:48:13Z","timestamp":1638845293000},"page":"13167","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PPAR\u03b3\u2014A Factor Linking Metabolically Unhealthy Obesity with Placental Pathologies"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1504-3639","authenticated-orcid":false,"given":"Sebastian","family":"Kwiatkowski","sequence":"first","affiliation":[{"name":"Clinical Department of Obstetrics and Gynecology, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kajdy","sequence":"additional","affiliation":[{"name":"Department of Reproductive Health, Centre of Postgraduate Medical Education St. Sophie\u2019s Obstetrics and Gynecology Hospital, 01-004 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8612-9344","authenticated-orcid":false,"given":"Katarzyna","family":"Stefa\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Medical University of Gda\u0144sk, 80-952 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-7774","authenticated-orcid":false,"given":"Magdalena","family":"Bednarek-J\u0119drzejek","sequence":"additional","affiliation":[{"name":"Clinical Department of Obstetrics and Gynecology, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8279-5585","authenticated-orcid":false,"given":"Sylwia","family":"Dzidek","sequence":"additional","affiliation":[{"name":"Clinical Department of Obstetrics and Gynecology, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Tousty","sequence":"additional","affiliation":[{"name":"Clinical Department of Obstetrics and Gynecology, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Soko\u0142owska","sequence":"additional","affiliation":[{"name":"Clinical Department of Obstetrics and Gynecology, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9847-6589","authenticated-orcid":false,"given":"Ewa","family":"Kwiatkowska","sequence":"additional","affiliation":[{"name":"Clinical Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"ref_1","first-page":"1838","article-title":"Obesity and Preeclampsia: Common Pathophysiological Mechanisms","volume":"19","author":"Barajas","year":"2008","journal-title":"Front. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"f6564","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980\u20132010: Age-period-cohort analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"BMJ"},{"key":"ref_4","unstructured":"American College of Obstetricians and Gynecologists (2013). Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet. Gynecol. Obs. Gynecol., 122, 1122\u20131131."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.semperi.2014.03.001","article-title":"Ischemic placental disease: A unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption","volume":"38","author":"Ananth","year":"2014","journal-title":"Semin. Perinatol."},{"key":"ref_7","first-page":"2033","article-title":"Ischemic placental syndrome\u2014Prediction and new disease monitoring","volume":"29","author":"Kwiatkowski","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11906-017-0757-7","article-title":"Pathophysiology and Current Clinical Management of Preeclampsia","volume":"19","author":"Amaral","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1: PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000477903","article-title":"Spanish Group for the Study of Angiogenic Markers in Preeclampsia Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1\/PlGF Ratio in Singleton","volume":"43","author":"Herraiz","year":"2018","journal-title":"Pregnancies Fetal Diagn. Ther."},{"key":"ref_11","unstructured":"Rana, S., Burke, S.D., and Karumanchi, S.A. (2020). Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am. J. Obstet. Gynecol."},{"key":"ref_12","first-page":"874","article-title":"Overweight and obesity at risk factors for hypertensive states of pregnancy: A retrospective cohort study","volume":"35","author":"Alba","year":"2018","journal-title":"Nutr. Hosp."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.annepidem.2004.12.008","article-title":"The risk of preeclampsia rises with increasing prepregnancy body mass index","volume":"15","author":"Bodnar","year":"2005","journal-title":"Ann. Epidemiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.2337\/db11-0174","article-title":"Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet\u2013fed mice","volume":"60","author":"Jiang","year":"2011","journal-title":"Diabetes"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G.A., Beguinot, F., and Miele, C. (2019). Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092358"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000471488","article-title":"The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function","volume":"10","author":"Goossens","year":"2017","journal-title":"Obes. Facts"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"L301","DOI":"10.1152\/ajplung.00004.2018","article-title":"Bayliss DA and Ravichandran KS. Pannexin 1 channels on endothelial cells mediate vascular inflammation during lung ischemia-reperfusion injury","volume":"315","author":"Sharma","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1152\/ajpregu.00529.2016","article-title":"Obesity-induced vascular inflammation involves elevated arginase activity","volume":"313","author":"Yao","year":"2017","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ajog.2005.06.041","article-title":"The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia","volume":"193","author":"Hendler","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cbf.3458","article-title":"The role of adiponectin in placentation and preeclampsia","volume":"38","author":"Fondjo","year":"2020","journal-title":"Cell Biochem. Funct."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/REP-16-0495","article-title":"Effects of maternal obesity on placental function and fetal development","volume":"153","author":"Howell","year":"2017","journal-title":"Reproduction"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.12688\/f1000research.19998.1","article-title":"Endothelial nitric oxide synthase-derived nitric oxide in the regulation of metabolism","volume":"9","author":"Tenopoulou","year":"2020","journal-title":"F1000Research"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: Regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med. Res. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.biopha.2017.06.036","article-title":"Inducible nitric oxide synthase: Good or bad?","volume":"93","author":"Lind","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2741\/4758","article-title":"Mechanisms of obesity-induced metabolic and vascular dysfunctions","volume":"24","author":"Atawia","year":"2019","journal-title":"Front. Biosci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Meza, C.A., La Favor, J.D., Kim, D.H., and Hickner, R.C. (2019). Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153775"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1753944715624853","article-title":"The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia","volume":"10","author":"Saleh","year":"2016","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/jhh.2016.17","article-title":"eNOS\/iNOS and endoplasmic reticulum stress-induced apoptosis in the placentas of patients with preeclampsia","volume":"31","author":"Du","year":"2017","journal-title":"Hum. Hypertens."},{"key":"ref_29","first-page":"825","article-title":"The effects of estradiol on inflammatory and endothelial dysfunction in rats with preeclampsia","volume":"45","author":"Lin","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"H661","DOI":"10.1152\/ajpheart.00202.2020","article-title":"Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia","volume":"319","author":"Qu","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/bs.apha.2016.04.008","article-title":"Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia","volume":"77","author":"Khalil","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/oby.21654","article-title":"Reactive Oxygen Species and Oxidative Stress in Obesity-Recent Findings and Empirical Approaches","volume":"24","author":"McMurray","year":"2016","journal-title":"Obesity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.imbio.2018.11.010","article-title":"Reactive oxygen species (ROS) in macrophage activation and function in diabetes","volume":"224","author":"Rendra","year":"2019","journal-title":"Immunobiology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1172\/JCI129186","article-title":"Metabolically healthy obesity: Facts and fantasies","volume":"129","author":"Smith","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_35","first-page":"405","article-title":"Metabolically Healthy Obesity","volume":"41","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_36","first-page":"399","article-title":"Normal-weight central obesity: Unique hazard of the toxic waiste","volume":"65","author":"Bosomworth","year":"2019","journal-title":"Can. Fam. Phys."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1210\/jc.2004-0631","article-title":"Regional adiposity and insulin resistance","volume":"89","author":"Garg","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3923\/pjbs.2019.168.173","article-title":"Measurement of Visceral Fat, Abdominal Circumference and Waist-hip Ratio to Predict Health Risk in Males and Females","volume":"22","author":"Ibrahim","year":"2019","journal-title":"Pak. J. Biol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-48382-5_1","article-title":"The Definition and Prevalence of Obesity and Metabolic Syndrome","volume":"960","author":"Engin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0026-0495(96)90040-2","article-title":"Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women","volume":"45","author":"Jensen","year":"1996","journal-title":"Metabolism"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI118083","article-title":"Relationship of generalized and regional adiposity to insulin sensitivity in men","volume":"96","author":"Abate","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/diab.45.12.1684","article-title":"Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM","volume":"45","author":"Abate","year":"1996","journal-title":"Diabetes"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2337\/diacare.46.10.1579","article-title":"Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat","volume":"46","author":"Goodpaster","year":"1997","journal-title":"Diabetes"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"jeb162958","DOI":"10.1242\/jeb.162958","article-title":"Heterogeneity of adipose tissue in development and metabolic function","volume":"221","author":"Schoettl","year":"2018","journal-title":"J. Exp. Biol."},{"key":"ref_45","first-page":"33","article-title":"Subcutaneous adipose tissue biology in metabolic syndrome","volume":"20","author":"Jialal","year":"2018","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm3198","article-title":"Forming functional fat: A growing understanding of adipocyte differentiation","volume":"12","author":"Cristancho","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Corrales, P.l., Vidal-Puig, A., and Medina-G\u00f3mez, G. (2018). PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19072124"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1191\/0960327102ht282oa","article-title":"Biology and toxicology of PPARgamma ligands","volume":"21","author":"Tugwood","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/db11-1419","article-title":"The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans","volume":"61","author":"Gustafson","year":"2012","journal-title":"Diabetes"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbrc.2020.08.105","article-title":"A hypothesis for insulin resistance in primary human adipocytes involving MRTF-A and suppression of PPAR\u03b3","volume":"533","author":"Hansson","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Aprile, M., Cataldi, S., Perfetto, C., Ambrosio, M.R., Italiani, P., Tat\u00e8, R., Bl\u00fcher, M., Ciccodicola, A., and Costa, V. (2020). In-Vitro-Generated Hypertrophic-Like Adipocytes Displaying PPARG Isoforms Unbalance Recapitulate Adipocyte Dysfunctions In Vivo. Cells, 9.","DOI":"10.3390\/cells9051284"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1042\/CS20200580","article-title":"Metformin alleviates hyperuricaemia-induced serum FFA elevation and insulin resistance by inhibiting adipocyte hypertrophy and reversing suppressed white adipose tissue beiging","volume":"134","author":"Su","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1152\/ajpregu.00257.2017","article-title":"Adipose cell size: Importance in health and disease","volume":"315","author":"Stenkula","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Naryzhnaya, N.V., Koshelskaya, O.A., Kologrivova, I.V., Kharitonova, O.A., Evtushenko, V.V., and Boshchenko, A.A. (2021). Hypertrophy and Insulin Resistance of Epicardial Adipose Tissue Adipocytes: Association with the Coronary Artery Disease Severity. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010064"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1172\/JCI129191","article-title":"Contribution of adipogenesis to healthy adipose tissue expansion in obesity","volume":"129","author":"Vishvanath","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00404-017-4429-2","article-title":"Polycystic ovary syndrome, adipose tissue and metabolic syndrome","volume":"296","author":"Delitala","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1128\/MCB.00192-09","article-title":"Hypoxia-inducible factor 1\u03b1 induces fibrosis and insulin resistance in white adipose tissue","volume":"29","author":"Halberg","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2011-1702","article-title":"Regulation of lipolysis in small and large fat cells of the same subject","volume":"96","author":"Laurencikiene","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Unamuno, X., G\u00f3mez-Ambrosi, J., Rodr\u00edguez, A., Becerril, S., Fr\u00fchbeck, G., and Catal\u00e1n, V. (2018). Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur. J. Clin. Investig., 48.","DOI":"10.1111\/eci.12997"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-319-48382-5_8","article-title":"What Is Lipotoxicity?","volume":"960","author":"Engin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","article-title":"Adipogenesis and metabolic health","volume":"20","author":"Ghaben","year":"2019","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1194\/jlr.R021089","article-title":"Adipose tissue stem cells meet preadipocyte commitment: Going back to the future","volume":"53","author":"Cawthorn","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/08977199308991582","article-title":"Bone morphogenetic protein-2 causes commitment and differentiation in C3Hl0T1\/2 and 3T3 cells","volume":"9","author":"Wang","year":"1993","journal-title":"Growth Factors"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1073\/pnas.0906266106","article-title":"BMP signaling pathway is required for commitment of C3H10T1\/2 pluripotent stem cells to the adipocyte lineage","volume":"106","author":"Huang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nature08816","article-title":"Transcriptional control of preadipocyte determination by Zfp423","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2004.11.005","article-title":"Kr\u00fcppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation","volume":"1","author":"Oishi","year":"2005","journal-title":"Cell Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"40409","DOI":"10.1074\/jbc.R110.182451","article-title":"Endogenous ligands for nuclear receptors: Digging deeper","volume":"285","author":"Schupp","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Huppertz, B., and Schleu\u00dfner, E. (2018). Die Plazenta: Grundlagen und Klinische Bedeutung, Springer GmbH.","DOI":"10.1007\/978-3-662-55622-1"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.placenta.2003.10.014","article-title":"Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia","volume":"25","author":"Chen","year":"2004","journal-title":"Placenta"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.placenta.2012.03.011","article-title":"Sex-specific basis of severe placental dysfunction leading to extreme preterm delivery","volume":"33","author":"Walker","year":"2012","journal-title":"Placenta"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbrc.2004.01.074","article-title":"Expression and function of PPARgamma in rat placental development","volume":"315","author":"Iseki","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR gamma is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol. Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1210\/jc.2004-0849","article-title":"Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy","volume":"90","author":"Waite","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2006.02.009","article-title":"The pleiotropic function of PPAR gamma in the placenta","volume":"249","author":"Schaiff","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jsgi.2005.03.004","article-title":"Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction","volume":"12","author":"Rodie","year":"2005","journal-title":"J. Soc. Gynecol. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.placenta.2006.12.006","article-title":"Involvement of PPARgamma in human trophoblast invasion","volume":"28","author":"Fournier","year":"2007","journal-title":"Placenta"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1074-7613(04)00030-5","article-title":"Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells","volume":"20","author":"Wang","year":"2004","journal-title":"Immunity"},{"key":"ref_80","first-page":"3808","article-title":"Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum","volume":"85","author":"Waite","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/jpm-2013-0039","article-title":"Peroxisome proliferator-activated receptorgamma (PPAR\u03b3) is down regulated in trophoblast cells of gestational diabetes mellitus (GDM) and in trophoblast tumour cells BeWo in vitro after stimulation with PPAR\u03b3 agonists","volume":"42","author":"Knabl","year":"2014","journal-title":"J. Perinat. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/HYPERTENSIONAHA.121.17267","article-title":"Induction of the PPAR\u03b3 (Peroxisome Proliferator-Activated Receptor \u03b3)-GCM1 (Glial Cell Missing 1) Syncytialization Axis Reduces sFLT1 (Soluble fms-Like Tyrosine Kinase 1) in the Preeclamptic Placenta","volume":"78","author":"Armistead","year":"2021","journal-title":"Hypertension"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"637251","DOI":"10.1155\/2014\/637251","article-title":"PPAR-\u03b3 Regulates Trophoblast Differentiation in the BeWo Cell Model","volume":"2014","author":"Levytska","year":"2014","journal-title":"PPAR Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/107155760100800606","article-title":"Vascular endothelial growth factor but not placental growth factor promotes trophoblast syncytialization in vitro","volume":"8","author":"Crocker","year":"2001","journal-title":"J. Soc. Gynecol. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1095\/biolreprod59.3.643","article-title":"Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast","volume":"59","author":"Athanassiades","year":"1998","journal-title":"Biol. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/19396368.2014.991881","article-title":"The balancing act\u2014PPAR-\u03b3\u2019s roles at the maternal-fetal interface","volume":"61","author":"Kadam","year":"2015","journal-title":"Syst. Biol. Reprod. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1210\/jc.2003-032042","article-title":"Oxidized lowdensity lipoproteins inhibit trophoblastic cell invasion","volume":"89","author":"Pavan","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_88","first-page":"1105","article-title":"The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids","volume":"87","author":"Schild","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"10714","DOI":"10.1038\/s41598-017-11180-6","article-title":"Peroxisome Proliferator-Activated Receptor Gamma in Obesity and Colorectal Cancer: The Role of Epigenetics","volume":"7","author":"Motawi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/REP-20-0354","article-title":"Animal models of pregnancy and human location: Alternatives to mice","volume":"160","author":"Carter","year":"2020","journal-title":"Reproduction"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/HYPERTENSIONAHA.111.179440","article-title":"Evidence implicating peroxisome proliferator-activated receptor-\u03b3 in the pathogenesis of preeclampsia","volume":"58","author":"McCarthy","year":"2011","journal-title":"Hypertension"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.reprotox.2008.08.001","article-title":"Case series of rosiglitazone used during the first trimester of pregnancy","volume":"26","author":"Haddad","year":"2008","journal-title":"Reprod. Toxicol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/endo-118-4-1567","article-title":"Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae","volume":"118","author":"Kliman","year":"1986","journal-title":"Endocrinology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.reprotox.2004.02.014","article-title":"Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman","volume":"18","author":"Yaris","year":"2004","journal-title":"Reprod. Toxicol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications\u2014A review","volume":"13","year":"2014","journal-title":"Nutr. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db06-1206","article-title":"N-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner","volume":"56","author":"Neschen","year":"2007","journal-title":"Diabetes"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/mend.11.6.0007","article-title":"Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay","volume":"11","author":"Krey","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11883-000-0067-3","article-title":"Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: Emerging insights for evolving paradigms","volume":"2","author":"Plutzky","year":"2000","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.11.004","article-title":"Fatty acids, eicosanoids and PPAR gamma","volume":"785","author":"Savoye","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbrc.2005.08.204","article-title":"Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells","volume":"336","author":"Zhaoa","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12986-017-0209-z","article-title":"DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPAR\u03b3 and its phosphorylation at Ser273 in 3T3-L1 adipocytes","volume":"14","author":"Song","year":"2017","journal-title":"Nutr. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-020-03689-8","article-title":"The influence of conjugated linoleic acid on the expression of peroxisome proliferator-activated receptor-\u03b3 and selected apoptotic genes in non-small cell lung cancer","volume":"466","author":"Drzewiecka","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2015.12.028","article-title":"Cooperative action of bioactive components in milk fat with PPARs may explain its anti-diabetogenic properties","volume":"89","author":"Parodi","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"111455","DOI":"10.1016\/j.yexcr.2019.05.036","article-title":"Effects of PPARs\/20-HETE on the renal impairment under diabetic conditions","volume":"382","author":"Ding","year":"2019","journal-title":"Exp. Cell Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.apsb.2017.05.005","article-title":"The potential of natural products for targeting PPAR \u03b1","volume":"7","author":"Rigano","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1056-8727(00)00124-0","article-title":"Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients","volume":"14","author":"Nakamura","year":"2000","journal-title":"J. Diabetes Complicat."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543776.2020.1703952","article-title":"Peroxisome proliferator-activated receptor agonists and antagonists: A patent review (2014-present)","volume":"30","author":"Takada","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1507\/endocrj.K10E-248","article-title":"Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals","volume":"58","author":"Son","year":"2011","journal-title":"Endocr. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cmet.2018.03.012","article-title":"A transcriptional circuit filters oscillating circadian hormonal inputs to regulate fat cell differentiation","volume":"27","author":"Zhao","year":"2018","journal-title":"Cell Metab."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1177\/1933719118756746","article-title":"Aspirin Ameliorates Preeclampsia Induced by a Peroxisome Proliferator-Activated Receptor Antagonist","volume":"25","author":"Zhang","year":"2018","journal-title":"Reprod. Sci."},{"key":"ref_111","unstructured":"Eurostat (2021). Body Mass Index (BMI) by Sex, Age and Educational Attainment Level [HLTH_EHIS_BM1E__custom_1162105], Eurostat."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/13167\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:42:05Z","timestamp":1760168525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/13167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":111,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222313167"],"URL":"https:\/\/doi.org\/10.3390\/ijms222313167","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]}}}